Status:

COMPLETED

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

Lead Sponsor:

Actelion

Conditions:

Pulmonary Hypertension

Eligibility:

All Genders

3+ years

Brief Summary

The REVEAL Registry™ is a multicenter, observational, U.S.-based study of the clinical course and disease management of pulmonary arterial hypertension (PAH) patients. All consecutive consenting patie...

Detailed Description

Pulmonary arterial hypertension (PAH) is a chronic, progressive, and often fatal disease characterized by severe constriction of the blood vessels in the lungs. Over the past decade, significant strid...

Eligibility Criteria

Inclusion

  • Newly diagnosed or previously diagnosed patients with WHO Group I PAH.
  • Documentation of the following hemodynamic parameters by right heart catheterization, performed at any time prior to study enrollment:
  • Mean pulmonary arterial pressure (mPAP) \>25 mm Hg at rest or mPAP \> 30 mm Hg with exercise contemporaneous with a pulmonary wedge pressure ≤ 18 mm Hg
  • Pulmonary wedge pressure ≤ 18 mm Hg
  • Pulmonary vascular resistance (PVR) ≥ 240 dynes.sec.cm-5 (i.e., ≥ 3.0 Wood units)

Exclusion

  • Patients who meet the criteria for inclusion into WHO Groups II, III, IV or V
  • Have not had documentation of hemodynamic criteria for PAH by right heart catheterization at some time preceding study entry and following development of symptoms associated with PAH.
  • Do not meet the required hemodynamic criteria for entry into the study

Key Trial Info

Start Date :

March 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

3515 Patients enrolled

Trial Details

Trial ID

NCT00370214

Start Date

March 1 2006

End Date

December 1 2012

Last Update

May 17 2013

Active Locations (54)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (54 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

University of Arizona Medical Center

Tucson, Arizona, United States, 85724

3

University of California, San Diego

La Jolla, California, United States, 92037

4

UCLA / VA Medical Center

Los Angeles, California, United States, 90073

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management | DecenTrialz